19.7
Agents antifongiques
L’amphotéricine B est un agent antifongique à large spectre qui exploite les différences structurelles entre les membranes cellulaires fongiques et ma…
Les agents antifongiques ciblent les champignons pathogènes pour empêcher la propagation des infections. Par exemple, l’amphotéricine B est l’un de ces agents qui cible la membrane cellulaire fongique.
L’amphotéricine B est une molécule amphipathique, contenant à la fois des régions hydrophobes et hydrophiles.
Les groupes mycosamine et acide carboxylique dans la région hydrophile se lient à l’ergostérol, un stérol prédominant dans la membrane plasmique fongique. Cette liaison stabilise l’insertion de la molécule dans la bicouche lipidique.
Une fois insérées, plusieurs molécules d’amphotéricine s’alignent avec les chaînes lipidiques environnantes et s’assemblent en canaux poreux.
Ces canaux permettent la fuite incontrôlée d’ions, en particulier du potassium, ce qui provoque un déséquilibre osmotique et conduit à la mort des cellules fongiques.
Dans un autre mécanisme, les molécules d’amphotéricine B s’alignent parallèlement à la bicouche lipidique.
Cette orientation séquestre l’ergostérol vers la surface de la membrane, perturbant ainsi l’intégrité structurelle de la membrane.
View the full transcript and gain access to JoVE Core videos
Q1: How does amphotericin B target fungal cells?
Amphotericin B is an amphipathic molecule with hydrophobic and hydrophilic regions that selectively bind to ergosterol, a sterol predominant in fungal plasma membranes. This binding exploits structural differences between fungal and mammalian cell membranes, enabling the drug to disrupt fungal cells while minimizing damage to human cells. The selective interaction with ergosterol underlies amphotericin B's antifungal activity.
Q2: What is the pore-formation mechanism of amphotericin B?
In the pore-formation model, amphotericin B molecules insert into the lipid bilayer and assemble into pore-like channels. Multiple amphotericin molecules align with surrounding lipid chains to form these oligomeric transmembrane channels. The pores allow uncontrolled leakage of intracellular ions, particularly potassium, disrupting ionic gradients and causing fungal cell death.
Q3: How does the surface-aligned model of amphotericin B differ from pore formation?
In the surface-aligned model, amphotericin B binds ergosterol while remaining parallel to the membrane rather than inserting through it. This alignment causes ergosterol clustering at the membrane surface, disrupting lipid organization and compromising membrane integrity without forming pores. This mechanism operates independently of transmembrane channel formation.
Q4: What role do reactive oxygen species play in amphotericin B's antifungal action?
Amphotericin B triggers production of reactive oxygen species (ROS), including superoxide anions, hydrogen peroxide, and hydroxyl radicals. These ROS cause oxidative damage to cellular components such as lipids, proteins, and nucleic acids. This oxidative stress mechanism operates independently of ergosterol binding, providing an additional fungicidal effect beyond membrane disruption.
Q5: What is the sponge model of amphotericin B action?
In the sponge model, amphotericin B aggregates sequester ergosterol into extracellular complexes rather than embedding in the membrane. These aggregates extract ergosterol from the bilayer, depleting it and impairing essential membrane functions. This mechanism represents an alternative pathway to fungal cell death distinct from pore formation or surface alignment.
Q6: Why does amphotericin B cause toxicity in human cells?
Although amphotericin B selectively binds ergosterol in fungal membranes, weak binding to cholesterol, the sterol predominant in mammalian cell membranes, contributes to toxicity in human cells. This off-target interaction with cholesterol can disrupt human cell membranes, limiting the drug's therapeutic window. The structural similarity between ergosterol and cholesterol accounts for this undesired cross-reactivity.
Q7: What structural features of amphotericin B enable its antifungal selectivity?
Amphotericin B's amphipathic structure features a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups. The mycosamine and carboxylic acid groups bind to ergosterol, stabilizing the molecule's insertion into the fungal lipid bilayer. This dual-region architecture allows selective recognition and targeting of fungal-specific membrane components.